Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 870 of 1,261

  1. US 8449877

    Pharmaceutically purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 28, 2013 · Expires May 23, 2033

    granted

  2. US 8449876

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  3. US 8449872

    Polymer conjugates of nesiritide peptides

    Nektar Therapeutics · Granted May 28, 2013 · Expires May 23, 2033

    granted

  4. US 8445491

    Wnt protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted May 21, 2013 · Expires May 16, 2033

    granted

  5. US 8445485

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  6. US 8445632

    Selective poly-N-substituted glycine antibiotics

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  7. US 8445445

    Method of promoting hair growth using FGFR4 extracellular domains

    Five Prime Therapeutics, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  8. US 8445509

    Fused heterocyclic derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 21, 2013 · Expires May 16, 2033

    granted

  9. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2013 · Expires May 16, 2033

    granted

  10. US 8445434

    IGF-1 fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  11. US 8445461

    Pharmaceutical composition for meniere's disease

    Setsuko Takeda · Granted May 21, 2013 · Expires May 16, 2033

    granted

  12. US 8445501

    Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines

    TAKEDA GMBH · Granted May 21, 2013 · Expires May 16, 2033

    granted

  13. US 8445473

    Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 21, 2013 · Expires May 16, 2033

    granted

  14. US 8445658

    Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted May 21, 2013 · Expires May 16, 2033

    granted

  15. US 8445507

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  16. US 8445541

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  17. US 8445588

    Hydrophilic copolymers and assemblies containing the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 21, 2013 · Expires May 16, 2033

    granted

  18. US 8445696

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  19. US 8445694

    Hydrazonopyrazole derivatives and their use as therapeutics

    Dermira (Canada), Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  20. US 8445714

    Cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  21. US 8445216

    Antibodies and immunotoxins that target human glycoprotein NMB

    The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted May 21, 2013 · Expires May 16, 2033

    granted

  22. US 8445021

    Functionalized magnetic nanoparticles and methods of use thereof

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  23. US 8444991

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted May 21, 2013 · Expires May 16, 2033

    granted

  24. US 8445251

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.